Cytrellis Biosystems, Inc.
Last verified 2026-05-19. JSON
| Total raised | $25.1M |
|---|---|
| Latest round | Funding round, $25.1M, 2024-12-20 |
| Founded | unknown |
| Headquarters | Woburn, MA |
| Industry | healthtech |
| Stage | unknown |
| Website | cytrellis.com |
Cytrellis makes Ellacor, an FDA-cleared device that uses proprietary Micro-Coring to remove sagging skin at micro-scale without conventional resurfacing. It targets aesthetic dermatology and plastic-surgery practices treating age-related skin changes. The hollow-needle Micro-Coring approach removes tissue with no thermal injury.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-12-20 | Funding round | $25.1M | undisclosed |
Detected tech stack
Nginx, jQuery Migrate 3.4.1, WordPress, WP Engine, PHP, MySQL, jquery 1.9.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $25.1M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $25.1M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | cytrellis.com, read 2026-05-19 |
| Description | self-reported | cytrellis.com, read 2026-05-19 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $25.1M, 2024-12-20 → Funding round, $25.1M, 2024-12-20, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $25.1M, 2024-12-20 → Funding round, $25.1M, 2024-12-20 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes